Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Nassal, Michael [VerfasserIn]   i
 Skamel, Claudia [VerfasserIn]   i
 Vogel, Maren [VerfasserIn]   i
 Kratz, Peter A. [VerfasserIn]   i
 Stehle, Thomas [VerfasserIn]   i
 Wallich, Reinhard [VerfasserIn]   i
 Simon, Markus M. [VerfasserIn]   i
Titel:Development of hepatitis B virus capsids into a whole-chain protein antigen display platform
Titelzusatz:new particulate Lyme disease vaccines
Verf.angabe:Michael Nassal, Claudia Skamel, Maren Vogel, Peter A. Kratz, Thomas Stehle, Reinhard Wallich, Markus M. Simon
Jahr:2008
Umfang:8 S.
Teil:volume:298
 year:2008
 number:1/2
 pages:135-142
 extent:8
Fussnoten:Available online: 20 September 2007 ; Gesehen am 14.05.2021
Titel Quelle:Enthalten in: International journal of medical microbiology
Ort Quelle:München : Elsevier, 2000
Jahr Quelle:2008
Band/Heft Quelle:298(2008), 1/2, Seite 135-142
ISSN Quelle:1618-0607
Abstract:The immunogenicity of peptides and small protein fragments can be considerably enhanced by their presentation on particulate carriers such as capsid-like particles (CLPs) from hepatitis B virus (HBV). HBV CLPs are icosahedral nanoparticles formed by 90 or 120 core protein dimers. Insertions into the immunodominant c/e1 B cell epitope, a surface-exposed loop on the HBV capsid protein, are especially immunogenic. Here we investigated whether the HBV core protein can be exploited as a vaccine carrier for whole-chain protein antigens, using two clinically relevant proteins derived from a bacterial human pathogen, the Lyme disease agent Borrelia burgdorferi. For this purpose we analyzed CLP formation by core fusions with the entire 255-amino-acid ectodomain of outer surface lipoprotein A (OspA), and with two distinct, 189 amino acid long variants of the dimeric OspC (OspC(a), OspC(b)) of B. burgdorferi. OspA appropriately inserted into the HBV core protein yielded a multimerization-competent fusion protein, termed coreOspA. Although only partially assembling into regular CLPs, coreOspA induced antibodies to OspA, including the Ig isotype profile and specificity for the protective epitope "LA-2", with an efficiency similar to that of recombinant lipidated OspA, the first generation vaccine against Lyme disease. Moreover, coreOspA actively and passively protected mice against subsequent challenge with B. burgdorferi. Fusions with the two OspC variants were found to efficiently form regular CLPs, most probably by OspC dimerization across different core protein dimers. In mice, both coreOspC preparations induced high-titered antibody responses to the homologous but also to the heterologous OspC variant, which conferred protection against challenge with B. burgdorferi. The data demonstrate the principal applicability of HBV CLPs to act as potent immunomodulator even for structurally complex full-length polypeptide chains, and thus open new avenues for novel vaccine designs.
DOI:doi:10.1016/j.ijmm.2007.08.002
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

Volltext: https://dx.doi.org/10.1016/j.ijmm.2007.08.002
 DOI: https://doi.org/10.1016/j.ijmm.2007.08.002
Datenträger:Online-Ressource
Sprache:eng
Sach-SW:Animals
 Antibodies, Bacterial
 B-Lymphocytes
 Borrelia burgdorferi
 Capsid
 Hepatitis B Core Antigens
 Hepatitis B virus
 Immunization
 Lyme Disease
 Lyme Disease Vaccines
 Mice
K10plus-PPN:1757851550
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68737756   QR-Code
zum Seitenanfang